Keywords
Gluteal tendinopathy, greater trochanteric pain syndrome, usual care, physiotherapy, education, exercise, clinical trial
-
Views
90
Downloads
How to cite this article
Almousa S, Vicenzino B, Mellor R et al. An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.12688/hrbopenres.13796.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
Export Citation
Sciwheel
EndNote
Ref. Manager
Bibtex
ProCite
Sente
▬
✚
Study Protocol
Clinical trial
An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT)
[version 1; peer review: 1 approved, 1 approved with reservations]
PUBLISHED 14 Dec 2023
OPEN PEER REVIEW
REVIEWER STATUS
Abstract
Corresponding author:
Sania Almousa
Competing interests:
No competing interests were disclosed.
Grant information:
Health Research Board [DIFA-2020-018].
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Copyright:
© 2023 Almousa S et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to cite: Almousa S, Vicenzino B, Mellor R et al. An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.12688/hrbopenres.13796.1)
First published: 14 Dec 2023, 6:76 (https://doi.org/10.12688/hrbopenres.13796.1)
Latest published: 28 Jun 2024, 6:76 (https://doi.org/10.12688/hrbopenres.13796.2)
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
There is a newer version
of this article available.
of this article available.
Introduction
Gluteal Tendinopathy (GT) is a degenerative condition of the gluteus medius and minimus tendons characterised by lateral hip pain at or around the greater trochanter of the hip, with marked palpation tenderness (Cook & Purdam, 2009). It is also known as Greater Trochanteric Pain Syndrome (GTPS). GTPS is an umbrella term used to describe pain over the greater trochanter of the lateral hip, primarily due to gluteus medius and/or minimus tendinopathy, with symptoms also potentially arising from the trochanteric bursa (Kong et al., 2007; Stephens et al., 2019). However, the terminology of gluteal tendinopathy is used when gluteus medius and/or minimus tendon changes are detected on Magnetic Resonance Imaging (MRI) (Dadour et al., 2021). Trochanteric bursitis has been shown to be present in less than 20% of those with lateral hip pain (Kong et al., 2007).
GT is the most common lower limb tendinopathy and three times more prevalent in women than men, affecting up to 25% of women aged over 40 years (Segal et al., 2007). One-year period incidence has been reported as 1.8/1000 in general practice (Riel et al., 2019). GT can result in very high levels of hip dysfunction, with consequent negative impact on general health and well-being, quality of life and employment status, similar to levels associated with end stage hip OA (Fearon et al., 2014; Plinsinga et al., 2018).
Along with structural changes in the gluteus medius and minimus tendons (Connell et al., 2003), individuals with GT have reduced hip abductor strength (Allison et al., 2016b) and higher external hip adduction moments during loading activities such as walking and stair-climbing (Allison et al., 2018; Allison et al., 2016a).
Abnormal hip biomechanics may predispose the development of GT. Specifically, it has been hypothesised that gluteal tendinopathy occurs due to compressive impingement of the gluteal tendons and bursa onto the greater trochanter by the iliotibial band (ITB) as the hip moves into adduction. Compressive forces are increased due to potential hip abductor muscle weakness, resulting in lateral pelvic tilt or ipsilateral shift in single leg stance, and relative hip adduction (Mellor et al., 2016).
Although this evidence highlights the rationale for strengthening as a key intervention, traditionally, corticosteroid injections have been used to achieve pain relief. The lack of evidence for the long-term benefits of steroid injection highlights that interventions that result in long-term benefits are required (Rompe et al., 2009). Additionally, steroid injections can weaken tendons, making them more vulnerable to tears (Kleinman & Gross, 1983; Park et al., 2013).
There is general consensus, in line with management of other tendinopathies, that interventions should aim to reduce compressive and tensile loads through education on how to minimise or adapt compressive activities and positions such as single-leg stance (walking, running and stair climbing), adduction-related activities such as sitting with legs crossed, certain hip stretches and sleeping positions (Cook & Purdam, 2009; Grimaldi & Fearon, 2015).
Although a range of conservative management approaches are generally recommended, best practice in the management of GTPS/gluteal tendinopathy remains unclear. A three-arm Randomised Controlled Trial (RCT) in Australia (LatErAl hiP pain (LEAP) trial) compared 14 sessions of EDucation on load management plus eXercise (EDX) over 8 weeks to a single corticosteroid injection (CSI), and a ‘wait and see’ comparison group on pain and global improvement in 204 individuals with GT. Results showed that at 8 weeks (completion of treatment), 77% of the EDX group were at least ‘moderately better’, compared with 58% in the injection group, and 29% in the wait-and-see group, with improvements maintained at one year (Mellor et al., 2018).
However, the number of physiotherapy treatments provided may not be feasible in some countries. For example, although exercise and education are the most common interventions for GT delivered by physiotherapists in Ireland, the number of physiotherapy sessions is usually limited to five or six (French et al., 2020). This treatment dosage is consistent across various musculoskeletal pathologies in the UK (Bury & Littlewood, 2018). Thus, whilst the LEAP trial in Australia demonstrated positive effects for EDX, delivery of this intervention over 14 sessions may not be practical in other healthcare systems, and evaluation of a lower dose of face-to-face sessions with a healthcare practitioner, which could be implemented into clinical practice is warranted.
Although current best evidence indicates, based on the LEAP trial findings, that a combination of physiotherapist-delivered exercise and education is most effective for management of GT, there are currently no clinical guidelines to guide practice. Indeed, usual care of gluteal tendinopathy by medical practitioners, to whom patients may initially present, is currently unknown.
This feasibility RCT will contribute to the following gaps in the literature: 1) to examine the feasibility of an RCT to compare effectiveness of six sessions of physiotherapy-led Education on load management plus eXercise (EDX-Ireland) EDX to usual care and 2) to quantify usual care in GT management in Ireland.
Completion of a daily HEP is essential to optimise exercise benefits and is an integral part of the EDX-Ireland intervention. Traditionally, paper-based diaries are used to record adherence, but adherence can be over-reported compared with electronic diaries (Stone et al., 2003). An RCT demonstrated improved exercise adherence using an app in people with musculoskeletal conditions, compared to paper handouts (Lambert et al., 2017), with high satisfaction rates reported by those who used the app. Given that >90% of phone users in Ireland have smartphones (Deloitte, 2023), the use of app-based technology may be potentially more feasible to monitor and enhance treatment adherence.
We therefore aim to evaluate the feasibility of conducting a definitive RCT, using a reduced dose (6 sessions) of a proven-effective physiotherapy treatment (14 sessions) consisting of EDucation plus eXercise for GT in an Irish context. A Study Within A Trial (SWAT) will compare smartphone application versus paper-based diary for exercise adherence measurement. A SWAT is a type of research study that has been embedded within a host larger trial to evaluate alternative ways of delivering or organising a particular trial process (Treweek et al., 2018).
Objectives
Specific objectives are as follows:
1. To assess recruitment and retention rates to inform a future definitive RCT
2. To estimate the effect size for a likely primary study outcome in a future definitive RCT
3. To determine the success of different patient recruitment methods (community recruitment, primary care and secondary care)
4. To identify the constituents of 'usual care' for gluteal tendinopathy in an Irish context and to determine if inclusion of a usual care arm in a future definitive RCT is feasible and appropriate without the potential for co-intervention bias
5. To assess outcome measure completion
6. To assess the feasibility of collecting healthcare utilisation and cost data for cost-effectiveness analysis
7. To assess if adherence to the home exercise programme (HEP) for those allocated to the EDX-Ireland intervention differs when recorded via a smartphone application compared with paper diaries
8. To assess the acceptability of the EDX-Ireland intervention and usual care from the perspective of study participants and service providers (treating therapists and providers of usual care)
9. To assess participants’ and therapists’ acceptability of a smartphone-based application (app) for exercise provision and home exercise adherence recording in the EDX-Ireland arm
10. To compare EDX with usual care on clinical outcomes including pain, function, hip abductor muscle strength, psychological measures, and quality of life.
Methods
Design and study setting
This feasibility, assessor-blinded RCT will take place in Dublin, Ireland. Telephone and physical screening will take place at RCSI University of Medicine and Health Sciences, while the EDX-Ireland intervention will be delivered in four physiotherapy clinics located in various northside and southside Dublin locations. The trial protocol follows the Standard Protocol Items: Recommendations for Interventional trials (SPIRIT) guidelines adapted for the reporting of protocol manuscripts of pilot and feasibility trials (Chan et al., 2013; French & Almousa, 2023b). An overview of the LEAP-Ireland procedure is outlined in Figure 1. The model consent form can be found as Extended data (French & Almousa, 2023a). The trial is registered prospectively on ClinicalTrials.gov (NCT05516563, 27/10/2022).
Figure 1. Overview of LEAP-Ireland procedures.
LEAP-Ireland, LatErAl hiP pain project; MRI, Magnetic Resonance Imaging.
Ethics approval
Ethics approval for this study has been granted by Research Ethics Committee of the Royal College of Surgeons in Ireland (RCSI) (REC202205010) on 19/08/2022, Irish College of General Practitioners (ICGP) (ICGP_REC_22_012) on 28/06/2022, Mater Misericordiae University Hospital (1/378/2303) on 25/10/2022, Beaumont Hospital (22/29) on 07/03/2023 and St Vincent's University Hospital (RC22-023) on 13/10/2022.
Participants
As the EDX programme in this trial has been designed specifically to address gluteal tendinopathy, other differential diagnoses for lateral hip pain such as hip osteoarthritis are excluded (Woodley et al., 2008) thus, various eligibility criteria will be applied.
Table 1 outlines the inclusion and exclusion criteria, which are based on the LEAP trial (Mellor et al., 2018).
Table 1. Inclusion and exclusion criteria.
Recruitment
Participants will be recruited from various sources, including rheumatology, orthopaedic and musculoskeletal triage clinics in three acute hospitals in Dublin, General Practitioners (GPs), social media and community recruitment throughout Dublin via advertisements in sports and leisure clubs and community organisations in Dublin.
Procedure
Initial screening for eligibility will be done via telephone by the Trial Manager (SA). If the phone interview indicates possible eligibility, potential participants will undergo a physical examination against specific selection criteria, undertaken by the Trial Manager. A battery of clinical tests will be used at the physical screening stage to clinically diagnose GT (Grimaldi et al., 2017). To be eligible, participants must experience pain on direct palpation of the gluteal tendon insertion on the greater trochanter, with reproduction of lateral hip pain on at least one of the following clinical tests: Hip Flexion, Adduction, External Rotation (FADER), resisted internal rotation in the FADER position (FADER-R), Flexion, Abduction, External Rotation (FABER), passive hip adduction in side lying (ADD), resisted isometric abduction in the ADD test position ADD-R), and a Single Leg Stance on the affected leg for 30 seconds (Mellor et al., 2016). Participants deemed eligible based on the clinical tests will then be referred for MRI to confirm the tendinopathic changes on MRI. Criteria for tendon pathology on MRI are described in Table 2.
Table 2. MRI classification of pathology for definition of gluteal tendinopathy (Mellor et al., 2016).
| T2 Hyperintensity around Greater Trochanter (representing oedema/fluid | |
|---|---|
| Size | (1) Tiny (thin slit of fluid) (2) Small (localized, mild distension) (3) Medium (localized, moderate distension) (4) Large (localized, marked distension) |
| Shape | (1) Feathery (2) Crescentic (3) Round (distended bursa) |
| Location | (1) Subtendinous (2) Intratendinous* (3) Subfascia lata (4) Superficial to fascia lata |
| Partial thickness tear | Tendon irregular, thinned or focally Discontinuous |
| Full thickness tear | Discontinuity and/or retraction of the torn tendon from greater trochanter |
Following phone, physical screening and imaging will be conducted to confirm eligibility. On attending the physical screening, the Trial manager will answer any queries and collect the signed and completed consent forms. Once participants complete the baseline assessment, they will be randomly allocated into one of two groups: (1) education and exercise programme (EDX-Ireland), or (2) usual care. Participants will complete the patient-reported outcomes (PROs) and abductor muscle strength assessment at baseline, 8 weeks, and 3 months.
Participants will be asked to refrain from other treatments during the trial period, but analgesia and anti-inflammatory drugs will be permitted. All medication use and co-interventions will be recorded via the healthcare utilisation questionnaire.
Blinding
The trial manager (SA) assessing outcome measures at baseline, 8 weeks and 3 months follow-up will be blinded to group allocation and will not be involved in randomisation or intervention delivery.
Randomisation and Concealed allocation
The randomisation schedule will be generated using a computer-generated random sequence in advance of trial commencement by the trial statistician (KB), who will not be involved in recruitment or outcome assessment. Randomisation will be stratified by recruitment method (GP, secondary care or community/social media). Participants will be randomly allocated (1:1 ratio) using random blocks of size 2, 4, 6, or 8 within each stratum. Within the intervention arm (n=32) a further 1:1 blocked randomisation (block size 2, 4 or 6) will be developed for random allocation of the EDX-Ireland group, within the SWAT, to either the smartphone application (n=16) or paper-based diaries (n=16). Randomisation and allocation will be done by the PI (HPF), who will not be involved in screening or baseline assessment of trial participants, thus maintaining concealed allocation.
Interventions
The EDX intervention is described based on the Template for Intervention Description and Replication (TIDieR) (Hoffmann et al., 2014).
The EDX-Ireland intervention will be delivered in four physiotherapy clinics located in northside and southside Dublin locations. Physiotherapists will have attended a training session outlining study objectives and requirements, demonstrating the detailed education material, the theoretical and practical part of the exercise protocol and progressions. Additionally, a detailed study manual will be provided for reference (Mellor et al., 2016).
The EDX-Ireland intervention will involve six face-to-face sessions with a physiotherapist, delivered over eight weeks (60 mins for the initial session and 30 mins thereafter). The sessions will be scheduled as weekly appointments for the first four weeks and the final two sessions will be delivered at fortnightly intervals. Participants will receive education on tendon care and gradual progression of tendon loading. The treating physiotherapist will also provide graduated exercise with 4-6 exercises performed six days a week, with alternate low and high load days, and one rest day. The exercise programme includes three key streams:
1. Isometric abduction: low load isometric abduction training in supine and standing, to improve muscle coordination and control, and to potentially assist with pain relief.
2. Functional loading: bridging (double-leg, offset and single-leg exercises) and squatting (double-leg, offset, single-leg stance and squat, step-ups) progressions with an emphasis on gluteal muscle recruitment and femoropelvic control.
3. Abductor loading: targeted frontal plane abductor muscle and tendon loading to improve load tolerance by applying progressively higher loads across the abductor muscles, as tolerated. This includes sidestepping tasks and standing band-resisted hip abduction.
Week 1 will focus on familiarisation with the basic program and load management strategies. Week 2 will involve early loading and optimisation of movement patterns in the base exercises. Weeks 3-8 focus on graduated loading, where participants will perform exercises, six days a week, with three of those days including exercises performed at a 'hard' to 'very hard' level. These hard days will alternate with three ‘light’ days’ and one rest day. The physiotherapist will monitor exercise difficulty level, exercise technique and pain response to exercise. Level of exercise difficulty will be monitored with the modified Borg Scale of Perceived Exertion (0-10 scale), where isometric abduction will be performed at a 'light' level (Borg 1-2), functional loading at a 'somewhat hard' to 'hard' level (4-6), and targeted abductor loading from 'somewhat hard' towards 'hard' to 'very hard' level (7-9), depending on response to loading.
Study Within A trial (SWAT)
To test objective 7, the 32 participants randomly allocated to the EDX-Ireland intervention will also be randomly allocated to either a ‘PhysiApp’ or ‘Diary’ group for recording of home exercises, using a second computer-generated random sequence, prepared by the trial statistician. Participants will be informed at the time of group allocation by the randomiser (HPF). Treating therapists will be provided with access to Physitrack (Physitrack Ltd, London, UK), an online exercise management system used by physiotherapists for exercise prescription for the duration of the recruitment and intervention period. Both groups (‘PhysiApp’ and ‘Diary’) will use the patient-facing companion app, PhysiApp (Physitrack Ltd, London, UK), for home exercises, but only the ‘PhysiApp’ group will record exercise adherence on the app. Those assigned to the ‘Diary’ group will be provided with a paper-based diary to record exercise completion and the exercise recording function in PhysiApp will be deactivated. Physiotherapists will check adherence at each appointment and assist with any barriers to exercise completion.
Usual care
Usual care was chosen for this study as the comparator to determine if it is an appropriate comparator, and to identify the exact constituents of usual care, in advance of conducting a full-scale RCT. Usual care for this trial is defined as the treatment that a participant has followed so far or has been prescribed by their referrer into the trial (i.e., GP, orthopaedic consultant, rheumatologist or musculoskeletal triage physiotherapist). For those not referred from a healthcare practitioner (e.g., community recruitment/social media), usual care may not be relevant, but any healthcare utilisation will be recorded on a pre-standardised form. Participants randomised to the Usual Care group will receive an information leaflet on their pathology and general advice on symptom management.
Intervention acceptability
To further explore trial feasibility and acceptability (objectives 8 and 9), semi-structured interviews will be conducted with approximately 18 participants (recruited from both groups) to explore their experiences of the trial, intervention content, face-to-face clinic interaction, HEP completion, and acceptability of the smartphone app or paper diaries for HEP recording. The topic guides will be developed using the Theoretical Framework of Acceptability (Sekhon et al., 2017). Semi-structured interviews will also be conducted with treating therapists to ascertain their perspectives of the acceptability of the EDX-Ireland intervention. Interviews will also be undertaken with healthcare professionals (doctors or musculoskeletal triage physiotherapists) who referred participants into the trial to explore their knowledge of management options for gluteal tendinopathy, their rationale for choice of usual care, as well as any barriers or facilitators to providing optimal care for gluteal tendinopathy. Interviews will be audio recorded and transcribed verbatim for thematic analysis.
Outcomes measures
Primary outcome measures. Primary outcomes focus on feasibility issues including success of recruitment and retention to the 3-month time point. Details of feasibility outcomes and methods used to collect these outcomes are outlined in Table 3.
Table 3. Feasibility outcomes.
Secondary clinical outcomes. The following secondary outcomes, which are aligned to core domains recommended for use in tendinopathy research (Vicenzino et al., 2019) will be assessed at baseline, 8 weeks and 3 months.
The Global Rating of Change (GROC) is a 15-point rating scale, completed by the patient based on their perceived overall change in their hip condition and ranges from –7(a very great deal worse) to +7 (a very great deal better) (Kamper et al., 2009) and allows patients to consider factors that they consider important for their clinical situation.
Pain severity will be measured using a 11-point Numerical Pain Rating scale (NPRS) under two conditions of pain; on activity/loading and pain in the last week. It is reliable, valid and easy to administer. A minimal important difference (MID) of 1.5 points or 15% has been ascertained for musculoskeletal pain (Abbott & Schmitt, 2014).
Victorian Institute of Sport Assessment-Gluteal (VISA-G) is a self-reported questionnaire, which measures disability associated with gluteal tendinopathy. It contains eight items, rated on an 11-point scale, related to pain and function and is reliable and valid (Fearon et al., 2015).
The Patient-Specific Functional Scale (PSFS) is a self-reported, patient-specific measure, designed to assess functional change. It is reliable and valid across various musculoskeletal disorders (Abbott & Schmitt, 2014).
Psychological distress, which is associated with gluteal tendinopathy (Plinsinga et al., 2018; Plinsinga et al., 2020) will be evaluated using two measures. The Pain Catastrophising Scale (PCS) is a valid and reliable 13-item self-report measure, which asks about thoughts and feelings associated with pain (Sullivan et al., 1995). The Patient Health Questionnaire (PHQ) is a valid and reliable self-reported questionnaire for measurement of depressive symptoms. It contains nine questions with a score range of 0-27. A score of ≥5 indicates mild depressive symptoms, ≥10 moderate, ≥15 moderately severe and ≥20 severe (Kroenke et al., 2001).
The Pain Self-Efficacy Questionnaire (PSEQ) assesses people’s confidence in performing activities when they are in pain (Nicholas, 2007). It contains 10 items answered on a 7-point Likert scale.
The EQ-5D-5L is a generic measure of health-related quality of life (HR-QOL). Each health state is ranked and transformed into a single index score, called the utility score. This utility score will be used to express the Quality-Adjusted Life Years (QALY), which is commonly used in analyses of cost-effectiveness (Rabin & de Charro, 2001).
The Central Sensitisation Inventory (CSI) is a 25-question self-reported screening instrument designed to identify presence of centrally-mediated pain sensitisation. A cut-off score of ‘40’ of ‘100’ yielded good (81%) sensitivity (Neblett et al., 2015).
Isometric Hip Abductor Muscle Strength will be tested in supine using a hand-held dynamometer (MicroFET®2 Digital Handheld Dynamometer (Hoggan Scientific, Utah, USA). The leg will be positioned to minimise compression of the gluteal tendons against the greater trochanter. A non-elastic fixation belt will be placed around the patient’s pelvis and secured to the bed to minimise any trunk/pelvic movement during testing (Allison et al., 2016b). Pain severity using a 0-10 NPRS will be assessed immediately before and during strength testing to ascertain the impact pain may have on maximal effort.
Healthcare use and costs will be measured using a modified version of the Osteoarthritis Cost and Consequences Questionnaire (OCC-Q) (Pinto et al., 2011; Wilson et al., 2023).
All assessments will take place at RCSI. Participants will complete PROs using Research Data Capture (REDcap) online electronic data capture tool (Harris et al., 2019), hosted at RCSI, for the baseline, 8-week and 3-month follow-up.
Adverse events
Adverse events related to the EDX intervention are considered low risk in this trial. Treating physiotherapists will record and report adverse effects to the Principal Investigator. Serious adverse events will be reported to the trial sponsor and may result in trial withdrawal.
Participant confidentiality and data management
Participants will be identified by a study-specific unique identifier number (UIN) during the study. Processing of any personal data will comply with national and EU General Data Protection Regulations (GDPR), and compliance with GDPR will be maintained throughout the trial.
Statistical analysis
Descriptive analysis will include proportions and 95% confidence intervals (CI), means and standard deviations (SD) or medians and inter-quartile ranges (IQR) where appropriate. Feasibility outcomes of recruitment and retention rates will be descriptively reported overall across both arms of the trial (percentages and 95% CIs) and by method of recruitment. Outcome measure completion will be described both by participant and by outcome measure using percentages. Recruitment rates will be calculated as the number of participants who consent to participate divided by the number of eligible participants approached. Trial retention rates will be calculated from the number of participants who complete all outcome measures divided by the number who record baseline outcome measures. Adherence rate of exercises within the SWAT for the EDX group, and types of usual care for the control group will be reported as percentages.
Results of secondary clinical outcomes including NPRS, hip abduction strength and measures of psychological distress will be reported using means and SD or medians and IQR, where appropriate for baseline, 8- and 3- month follow-up. Statistical analysis will be performed using Stata v17 (StataCorp, College Station, Texas, USA).
Sensitivity analysis will be conducted as a secondary analysis to impute any missing data using multiple imputation. The resource use data captured by the OCC-Q will be valued using unit costs derived from local and national sources and will be analysed in a manner consistent with the clinical outcome data.
Qualitative data from interviews will be transcribed verbatim. A two-stage analysis will be undertaken, initially through inductive line-by-line coding of the extracted results to identify emergent themes, followed by deductive mapping of pre-identified codes to the Theoretical Framework of Acceptability (Sekhon et al., 2017).
Trustworthiness will be attained through procedures such as member checking, maintaining a reflexive journal of the research procedures and a clear audit trail of the process (Braun & Clarke, 2014).
Sample size
We will aim to recruit 64 participants. A sample of 60 participants (n=30 per arm of the trial) would provide an estimate of the recruitment rate of ≥50% (95% confidence interval (95% CI) 37.3% to 62.7%), and an estimated retention rate of ≥80% (95% CI of 69.8% to 90.2%). To ensure balance within each stratum, sample size will be increased to 64 with 32 allocated to each arm. This sample size will also allow for the potential effect of the primary outcome (GROC) between the two groups to be determined for powering a larger definitive trial.
Patient and Public Involvement
This study embeds Patient and Public Involvement (PPI) in its overall approach and processes. To date, PPI actions have included contribution to outcome measures, study logo, recruitment strategies and participant-facing information regarding study recruitment materials.
Trial governance and data management
This study will be conducted in accordance with international standards of Good Clinical Practice in trials. A Trial Management Committee (TMC) and a Trial Steering Committee (TSC) will be established to ensure adequate trial management, governance and safety monitoring for the trial. The Trial Management Group will be responsible for data management and stewardship, under the leadership of the principal investigator.
All data will be handled in accordance with RCSI research policies and ethical principles. The FAIR principles will be adhered to, to ensure Findability, Accessibility, Interoperability and Reusability. Research data will be stored on a unique SharePoint site at RCSI, managed, processed, and stored in a secure environment, and regularly and securely backed up by the RCSI IT department. Any data will be encrypted at source and transferred using secure methods that comply with RCSI data management policies and data protection policies for storage on the RCSI SharePoint site. Access to research files will be restricted to the research team. Data will be stored for a minimum of five years in line with HRB and RCSI guidelines on good research practice and general audit requirements.
Discussion
Gluteal tendinopathy is the most common lower limb tendinopathy, which can negatively impact everyday function and quality of life. We aim to evaluate the feasibility of a future definitive RCT to test the delivery of a lower dose (6 sessions) of a 14-session education and exercise programme, which demonstrated short and long-term improvement compared with corticosteroid injection and ‘wait-and-see’ (Mellor et al., 2018). Current evidence suggests that GT management needs targeted interventions, which improve the ability of the gluteus medius and minimus tendons to tolerate load required for everyday activities, and to strengthen the associated muscles, as well as minimising compressive load.
Exercise and load management are recommended as the cornerstone of an effective non-invasive management of tendinopathy (Cook et al., 2016). The exercise and load management programme to be used in this study is focused specifically on hip abductor muscle function, commencing at low load and gradually progressing over the course of the 8-week period, as well as avoiding compressive loads on the gluteal tendons, such as adopted/prescribed hip muscle stretching techniques (Mellor et al., 2016).
Additionally, this study will quantify current usual care for this condition. Whilst numerous systematic reviews of interventions for GT/GTPS have been published, no clinical guidelines have been developed to provide guidance on what usual care for this condition should include (Barratt et al., 2017; Gazendam et al., 2022; Koulischer et al., 2017). Usual care is a common comparator in intervention trials, and whilst it is a term used to describe current treatments used by clinicians, it is commonly unclear how it is defined and may be inconsistent, highly variable and non-evidence based (Angriman et al., 2019; Pascoe et al., 2022). Findings from this feasibility trial should elucidate what typical care entails across primary and secondary care settings and may be used to inform decisions for comparators for a future definitive RCT.
Download
Export To
CITE
how to cite this article
Almousa S, Vicenzino B, Mellor R et al. An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.12688/hrbopenres.13796.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.
Open Peer Review
Current Reviewer Status:
Key to Reviewer Statuses
VIEW
HIDE
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 14 Dec 2023
Views
22
How to cite this report:
Fearon A. Reviewer Report For: An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.21956/hrbopenres.15095.r38734)
The direct URL for this report is:
https://hrbopenresearch.org/articles/6-76/v1#referee-response-38734
https://hrbopenresearch.org/articles/6-76/v1#referee-response-38734
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.
Reviewer Report 11 Apr 2024
Approved with Reservations
VIEWS 22
The authors plan to test the feasibility of conduction an RCT into the effectiveness of an amended LEAP protocol, 6 sessions over 8 weeks, compared to the original of 14 session. This is a very worthwhile project.
... Continue reading
... Continue reading
CITE
HOW TO CITE THIS REPORT
Fearon A. Reviewer Report For: An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.21956/hrbopenres.15095.r38734)
The direct URL for this report is:
https://hrbopenresearch.org/articles/6-76/v1#referee-response-38734
https://hrbopenresearch.org/articles/6-76/v1#referee-response-38734
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
-
Author Response 28 Jun 2024Sania Almousa, School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland28 Jun 2024Author ResponseThank you very much for reviewing this protocol and for your insightful feedback. The protocol has been amended to address your comments. Please see below a point by point response ... Continue reading
COMMENTS ON THIS REPORT
-
Author Response 28 Jun 2024Sania Almousa, School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland28 Jun 2024Author ResponseThank you very much for reviewing this protocol and for your insightful feedback. The protocol has been amended to address your comments. Please see below a point by point response ... Continue reading
Views
17
How to cite this report:
Clifford C and Monnington K. Reviewer Report For: An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.21956/hrbopenres.15095.r37534)
The direct URL for this report is:
https://hrbopenresearch.org/articles/6-76/v1#referee-response-37534
https://hrbopenresearch.org/articles/6-76/v1#referee-response-37534
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.
Reviewer Report 23 Mar 2024
Katie Monnington,
Royal National Orthopaedic Hospital NHS Trust, London, UK
Approved
VIEWS 17
Reviewer 1:
General Comments
General Comments
- Thank you for submitting your research protocol. This manuscript describes a feasibility randomised controlled trial (RCT) protocol where the authors intend to compare the effect of education plus exercise (EDX) to
CITE
HOW TO CITE THIS REPORT
Clifford C and Monnington K. Reviewer Report For: An EDucation and eXercise intervention for gluteal tendinopathy in an Irish setting: a protocol for a feasibility randomised clinical trial (LEAP-Ireland RCT) [version 1; peer review: 1 approved, 1 approved with reservations]. HRB Open Res 2023, 6:76 (https://doi.org/10.21956/hrbopenres.15095.r37534)
The direct URL for this report is:
https://hrbopenresearch.org/articles/6-76/v1#referee-response-37534
https://hrbopenresearch.org/articles/6-76/v1#referee-response-37534
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
-
Author Response 28 Jun 2024Sania Almousa, School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland28 Jun 2024Author ResponseThank you very much for reviewing this protocol and for your insightful feedback. The protocol has been amended to address your comments. Please see below a point by point response ... Continue reading
COMMENTS ON THIS REPORT
-
Author Response 28 Jun 2024Sania Almousa, School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland28 Jun 2024Author ResponseThank you very much for reviewing this protocol and for your insightful feedback. The protocol has been amended to address your comments. Please see below a point by point response ... Continue reading
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations -
A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Competing Interests Policy
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Examples of 'Non-Financial Competing Interests'
- Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.
- You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.
- You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).
- You work at the same institute as any of the authors.
- You hope/expect to benefit (e.g. favour or employment) as a result of your submission.
- You are an Editor for the journal in which the article is published.
Examples of 'Financial Competing Interests'
- You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.
- You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.
- You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.
Stay Updated
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Comments on this article Comments (0)